Medi-Span Releases Controlled Substances File to Help U.S. Customers Meet Compliance Requirements at

Before you go, we thought you'd like these...
Before you go close icon

Medi-Span Releases Controlled Substances File to Help U.S. Customers Meet Compliance Requirements at Federal, State, and Territory Level

INDIANAPOLIS--(BUSINESS WIRE)-- Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that its embedded drug data solution, Medi-Span®, is releasing a Controlled Substances File™ to help healthcare organizations meet mandatory U.S. compliance requirements and to support quality assurance programs. The file data assists pharmacies, payers, EMR/CPOE vendors, and hospitals in adhering to prescribing, dispensing, and reporting requirements by identifying controlled substances schedules at the federal, state, and U.S. territory level.

Along with federal regulations of controlled substances through the Drug Enforcement Agency, individual states and U.S. territories may also have their own regulations that may differ from each other and those at the federal level. The Controlled Substances File assists organizations by providing support for compliance at all levels. It also identifies controlled substances by National Drug Code (NDC), enabling compatibility with a variety of databases and drug information systems. EMR and CPOE vendors and self-programmers can employ the file to develop rules, applications, and reports based on the needs of their users, aiding in the creation of quality assurance programs around controlled substances.


"Due to concerns over prescription drug abuse, government authorities in the U.S. continue to increase verification, monitoring, and reporting requirements for controlled substances," said David Del Toro, Vice President & General Manager, Clinical Drug Information, Wolters Kluwer Health, Clinical Solutions. "The Medi-Span Controlled Substances File was designed based on customer feedback to help make meeting compliance easier by reducing the time spent manually researching and monitoring the varying federal, state, and territory restrictions on controlled substances."

About Wolters Kluwer Health

Medi-Span is part of Wolters Kluwer Health, a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company with annual revenues (2012) of €3.6 billion ($4.6 billion), approximately 19,000 employees worldwide and operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America.



Wolters Kluwer Health|Clinical Solutions
Margi Herwald Zitelli, Marketing Communications Specialist, 330-650-6506
Margi.HerwaldZitelli@wolterskluwer.com

KEYWORDS:   United States  North America  Indiana

INDUSTRY KEYWORDS:

The article Medi-Span Releases Controlled Substances File to Help U.S. Customers Meet Compliance Requirements at Federal, State, and Territory Level originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Want more news like this?

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners